The purpose of this study is to investigate the effect of probiotics in enteral nutrition on improving gut function, inflammatory markers and clinical outcomes in critically ill patients admitted to the intensive care unit.
Gut failure in critically ill patients is common. Enteral feeding is one of the preferred routes for nutrition support to maintain gut function. However, enteral nutrition is not without complications such as alterations in gut transit time and gut eco-culture. Enteral nutrition supplemented with a probiotic offers a possible solution to modulating this ecosystem. Objectives: The primary aim of this study was to investigate the effect of probiotics in enteral feeding on improving the gut function, inflammatory markers and clinical outcomes in critically ill patients. Subjects and Methods: Forty-nine patients that were admitted to the intensive care unit in University Malaya Medical Center requiring enteral feeding were randomized to receive either probiotics or a placebo. Patients remained in the intensive care unit for more than 7 days and were examined prior to the start of enteral feeding and on day 8. Return of gut function was assessed by the time needed to achieve caloric requirement. Inflammatory markers including the White Cell Count and C-reactive protein levels were tested on day 1 and day 8. Clinical outcome was assessed by number of days of ventilation and total days in intensive care unit.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
49
University Malaya Medical Center
Kuala Lumpur, Kuala Lumpur, Malaysia
Improve the time to return of gut function in patient on enteral feeding in intensive care unit
Probiotic/placebo administered once enteral feeding is started, and the hours needed to achieve maximum feeding is calculated in hours
Time frame: Time required to achieve maximum enteral feeding with a minimum of 48 hours
Inflammatory markers
Measure of inflammatory markers are obtained from patients at the start and at the end of probiotic/placebo administrations.
Time frame: 7-14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.